Physician profile
Phillip E Mason
NPI 1952390841
$9,463.21
in general payments reported to CMS, 2019-2025
8 companies · $8,074 in 2025
The $8,074 reported for 2025 was more than what 94% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $479 · 2023: $249 · 2024: $661 · 2025: $8,074.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,395 · Honoraria: $2,767 · Travel and Lodging: $1,097 · Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,395.00 |
| Honoraria | $2,766.67 |
| Travel and Lodging | $1,096.56 |
| Food and Beverage | $726.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maquet Cardiopulmonary Gmbh | $7,905.83 | 2025 | Hls Set |
| Getinge USA Sales, LLC | $463.90 | 2022-2025 | Cardiohelp, Cardiohelp |
| Maquet Cardiovascular L.L.C. | $395.00 | 2024 | Hls Set |
| Abbott Laboratories | $227.47 | 2022-2023 | 2nd Gen Centrimag Primary Console |
| Livanova USA, INC. | $175.85 | 2022 | |
| United Therapeutics Corporation | $122.79 | 2022 | |
| Abiomed | $121.86 | 2024 | Impella |
| Fresenius USA Marketing, INC. | $50.51 | 2025 | Novalung System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.